See also this year's filing and all EDGAR filings for this company.
PDF Report 0001377121_2023_Protagonist_Therapeutics_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001377121, Protagonist Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 243,077,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,565,000 |
| 3 | remainder_Assets | 3,286,000 |
| 4 | LiabilitiesCurrent | 31,179,000 |
| 5 | LiabilitiesNoncurrent | 1,141,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,739,000 |
| 9 | ResearchAndDevelopmentExpense | 126,215,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 26,581,000 |
| 12 | remainder_NetIncome | 3,980,000 |
| 13 | remainder_ComprehensiveNetIncome | -60,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 247,928,000 |
| 1 | Liabilities | 32,320,000 |
| 2 | Expenses | 157,954,000 |
| 3 | Revenues | 26,581,000 |
| 4 | StockholdersEquity | 215,608,000 |
| 5 | NetIncome | -127,393,000 |
| 6 | ComprehensiveNetIncome | -127,423,000 |
| 7 | BaseVar | 234,411,500 |
| 8 | EconomicCapitalRatio | 1.74 |
Edgar->Model Mapping
Feature Distribution
Change over Time
